Linc AB (LINC.ST) has a MoatMap StockRank of 44/100 based on Quality (55/100), Value (41/100), and Momentum (35/100) factor scores. The current signal is HOLD. Linc AB is a Swedish life science investor. While it provides exposure to early-stage Nordic biotech, it functions more like a venture capital fund with highly unpredictable cash flows, failing our requirement for stable owner earnings.
Linc AB is a Swedish investment company dedicated to the life science sector, investing in product-oriented companies within pharmaceuticals, medical technology, and diagnostics. Led by experienced industry professionals, the firm acts as an active owner to accelerate the commercialization of innovative medical technologies. Linc provides investors with diversified exposure to high-potential, early-to-mid-stage Nordic healthcare innovations.
| Price | $7.87 |
| Market Cap | $463M |
| P/E (TTM) | 10.06 |
| Price/Book | 0.99 |
| Return on Equity | 10.4% |
| Return on Invested Capital | -9.2% |
| Gross Margin | 100.0% |
| Operating Margin | 102.0% |
| Free Cash Flow | $3M |
Linc AB operates in the Asset Management industry, part of the Financial Services sector (Sweden).